伴有乳房良性病变的巨乳缩小术27例

目的 探讨乳房肥大下垂同时伴有良性病变的巨乳缩小术的方法。方法：1980年11月～2001年12月，共收治乳房肥大下垂伴乳腺良性病变的患者27例52侧，根据乳腺病变的性质、部位、大小以及乳房肥大下垂的程度，选择下述不同的术式，行下方垂直蒂瓣法9例(17侧)，垂直双蒂瓣法16例(3l侧)，双环形切口乳房缩小术2例(4侧)。结果 术后外观评价良25例49侧占94．2％，差2例3侧占5．8％。术后乳房疼痛改善率为95．8％，肩、背痛，睡眠明显改善为100％，乳房下皱襞湿疹、皮炎未再发生为100％，27例患者术后着装均满意。结论 乳房缩小整形手术是治疗乳房肥大下垂，同时伴有乳腺良性病变的首选治疗方法。     

伴有乳房良性肿物的乳房肥大下垂缩小术

目的 介绍伴有乳房良性肿物的乳房肥大下垂缩小术的方法和效果。方法 1990年12月至2001年11月，共收治乳房肥大下垂伴乳房良性肿物的患者15例29例，其中，伴有错构瘤1例，腺纤维瘤1例，小叶增生伴乳腺纤维瘤2例，轻度乳头状瘤2例，导管扩张伴分泌物潴留2例，小叶及腺管增生7例，行垂直下蒂真皮瓣缩乳术9例，垂直双蒂真皮瓣缩乳术6例。结果 15例29侧乳房，成功率89.6%，3侧乳头坏死，手术后因乳房肥大下垂带来的合并症明显好转。结论 乳房缩小整形手术是治疗乳房肥大下垂同时伴有乳房良性肿物的首选方法，可以达到治疗和美容的双重效果。     

改良无垂直瘢痕下蒂瓣法乳房缩小成形术45例疗效分析

目的 探讨改良无垂直瘢痕下蒂瓣法治疗巨乳症的效果.方法 回顾性分析郑州大学第一附属医院整形外科2015-01—2019-12行无垂直瘢痕下蒂瓣法乳房缩小成形术的45例巨乳症患者的临床及随访资料.结果 术后随访3～39个月.末次随访,45例患者术后乳房形态综合评分为87.22(3.26)分,高于术前的54.82(5.35...     

外侧上蒂式旋转乳房缩小成形术

目的:对女性巨乳症患者,采用一种矫正新术式,以达到乳房外形更加谐调完美的效果。方法:从1989年至2004年对26例52只女性巨乳症者,应用外侧上蒂式旋转乳房缩小成形术治疗。结果:术后随访26例患者6月至2年,乳房肥大下垂得到理想矫正,乳头勃起功能正常,未出现乳头乳晕感觉异常,切口瘢痕隐蔽不明显,整体外形美观。结论:通过该术式治疗实践,该法简单灵活、安全可靠、术后功能和形态满意。     

上方宽蒂垂直切口乳房缩小成形术

目的 探讨一种减少患者乳头乳晕坏死的上方宽蒂垂直切口乳房缩小成形术.方法 采用Lejour穹窿顶式手术设计,切除乳房下方的皮肤、腺体,乳头乳晕以上方真皮腺体组织宽蒂抬高到正常位置,进行乳房塑形,术后仅留有垂直瘢痕.结果 采用上方宽蒂垂直切口方法行乳房缩小成形术46例,其中4例为单侧乳房缩小,手术效果满意,乳房形态良好.14侧乳房切口部分裂开,其中3侧经清创缝合愈合,其余经换药后愈合,无乳头乳晕坏死发生.结论 上方宽蒂垂直切口乳房缩小成形术效果良好,减少了乳头乳晕坏死的危险,值得推广应用.     

突发性青春期巨乳症的诊断和治疗(附4例报告)

目的 探讨突发性青春期巨乳症的命名,诊断和巨大乳房缩小手术的治疗方法.方法 对4例突发性青春期巨乳症,用改良垂直双蒂进行缩小手术.结果 4例患者术后乳头、乳晕及两侧皮瓣血运良好,术区一期愈合,效果满意.结论 突发性青春期巨乳症,手术治疗是最佳选择,因乳房巨大,为保证其乳头、乳晕血运及术后外形,采用改良垂直双蒂法乳房缩小是较好的手术方法.     

双环形切口内上侧蒂巨乳缩小术的临床观察

目的探讨双环形切口内上侧蒂巨乳缩小术在临床中的应用效果。方法自2016年11月至2019年1月,对收治的33例巨乳症患者采用双环形切口内上侧蒂巨乳缩小术,术中切除乳腺外侧及部分上极腺体,保留内上象限脂肪腺体组织为蒂,将原乳头上提并固定于新设计的乳头位置,乳晕周围行荷包缝合,进行乳房塑形。结果本组33例患者,术后随访6～12个月,效果总体满意度较高。其中1例发生脂肪液化,经2次清创引流后愈合;1例右侧乳房出现部分乳头、乳晕坏死,考虑为过度折叠内上蒂所致;未发生感染和乳头感觉消失等并发症,乳房外形较好。结论采用双环形切口内上侧蒂巨乳缩小术,术后乳沟较明显,乳房上极饱满、形态较好,且瘢痕不明显。     

双环加垂直切口的乳房上提缩小术

目的:探讨结合不同术式的新乳房上提缩小术。方法:2012年1月以来,应用双环加垂直切口的乳房上提缩小方法行8例手术。结果:乳房肥大下垂得到明显矫正,乳头按需要上提3～7cm,切除乳腺组织100～350g,乳房外形挺拔,医患双方均比较满意。结论:双环加垂直切口的乳房上提缩小术是一种较好的手术方法。     

双环中心蒂法乳房缩小术

目的 探讨双环中心蒂乳房缩小术矫治乳房肥大下垂的方法 和疗效.方法 采用环绕乳晕内、外的2个环形切口,形成以乳头为中心的中央真皮帽,楔形或双S形切除多余腺体组织,保留第4肋间神经走行的乳腺组织的完整性,塑形后用真皮帽固定塑形.自2009年4月至2012年5月,采取上述方法 治疗乳房肥大伴不同程度下垂患者12例(24侧).结果 本组患者12例,术后切口均Ⅰ期愈合,经随访3～24个月,乳房外形良好,瘢痕轻微,乳头-乳晕感觉良好.结论 双环中心蒂乳房缩小术设计、操作简单,术后可确保乳头-乳晕的血供和感觉,是矫治乳房肥大下垂的有效方法.     

垂直瘢痕上方蒂乳房缩小成形术矫治乳房肥大下垂

目的 探讨垂直瘢痕上方蒂乳房缩小成形术的方法和疗效.方法 经乳晕外周环形切口,切除乳房下部皮肤、乳腺组织,将乳头乳晕上方的真皮腺体蒂上提至合理位置后进行乳房塑形.自2005年9月至2010年5月,治疗了58例乳房肥大患者.结果 术后随访所有患者3～24个月,其中乳头乳晕坏死者1例,经小阴唇皮瓣再造后效果满意;切口缝线裂斤者2例,经引流降乐后愈合;余者均取得了良好的乳房形态,正面观仅见于乳房下部垂直瘢痕.结论 垂直瘢痕上方蒂乳房缩小成形术可有效地缩小乳房体积,并使乳房上提,且术后瘢痕较轻,是矫正乳房肥大下垂的良好术式.     

单纯型和复杂型巨乳症的诊断及治疗

目的：探讨单纯型和复杂型巨乳症的临床特点,诊断要点及治疗方法,方法：回顾性分析1990－2000年民治21例巨乳症（37个乳房）,包括单纯型巨乳症16例29个乳房,复杂型巨乳症（巨乳症合并纤维腺瘤病等广范围病变者）5例8个乳房的临床,病理资料,结果：患者平均年龄23岁,21例均行手术治疗,16例单纯巨乳症者施以常规缩乳术,5例复杂型巨乳症中,2例为双乳腺纤维腺瘤病合并巨大型巨乳症,采用皮下腺体切除一期乳房成形术,2例几乎占据全乳的单乳巨纤维腺瘤并巨乳症,1例行皮下肿瘤切除,1例行肿瘤切除乳房成形术;1例双乳腺腺有块样物形成者行选择性腺体大部分切除乳房成形术。经随访至今患者乳房外形满意无肿瘤复发,结论：巨乳症好发于青春发育少女和青年妇女,诊断时应注意区别单纯型巨乳症和复杂型巨也症,术前B超,术中仔细探查及快速病检是必要的,单纯巨乳症常规缩乳术即可,复杂型巨乳症则应区别对待,彻底切除病变,一期乳房成形获得满意疗效,乳腺纤维腺瘤病合并巨乳症者,可采用皮下乳腺切除,真皮及皮下组织蒂一期乳房成形术。     

Y-Scar Vertical Mammaplasty for Treatment of Mild Macromastia with Pseudoptosis

Y-scar vertical mammaplasty is a technical modification of vertical scar breast reduction, which avoids superior areolar scarring. It has been previously shown to be particularly useful in young patients with mild macromastia and minimal or no ptosis. This case report presents a new indication for which to apply this technical approach. A 58-year-old patient presented with mild macromastia of mainly the inferior pole and pseudoptosis. Since there was no need to transpose the nipple, a Y-scar vertical mammaplasty was performed, removing tissue from the lower pole and preserving upper-pole fullness. Furthermore, superior areolar scarring was avoided. In conclusion, Y-scar vertical mammaplasty may find its use in other less commonly seen patient profiles such as this presented case of an older patient with slightly enlarged breasts and pseudoptosis.     

Symptomatic Macromastia: A Quality of Life Evaluation after Reduction Mammaplasty

Abstract: The aim of this retrospective study is to present the severity of symptoms and clinical signs attributed to macromastia and the extent to which reduction mammaplasty relieves them. We studied, both by specially designed questionnaires and review of their clinical records, 92 patients, aged 18–64 years, who underwent bilateral reduction mammaplasty for symptomatic macromastia. The most common symptoms were breast pain and discomfort, shoulder grooving and pain, back and neck pain, intertrigo, and in one case, ulnar paraesthesia. The mean weight of removed tissue from each breast was 720 g. The complication rate was 11%, the most frequent being postoperative infection. The mean follow-up period was 27 months. Postoperatively 88 patients presented with significant improvement of symptoms, whereas in 3 patients the breast discomfort persisted apparently due to residual fibrocystic elements. The majority of patients would recommend the operation to friends and relatives with macromastia. The significant degree of symptom recess supports the reconstructive value of reduction mammaplasty.     

Vertical reduction mammaplasty utilizing the superomedial pedicle: is it really for everyone?

Background: Classically, the vertical-style reduction mammaplasty utilizing a superomedial pedicle has been limited to smaller reductions secondary to concerns for poor wound healing and nipple necrosis. Objectives: The authors reviewed a large cohort of patients who underwent a vertical-style superomedial pedicle reduction mammaplasty in an attempt to demonstrate its safety and efficacy in treating symptomatic macromastia. Methods: A retrospective review was performed of 290 patients (558 breasts) who underwent a vertical-style superomedial pedicle reduction mammaplasty. All procedures were conducted by one of 4 plastic surgeons over 6 years (JDR, MAA, DLV, DRA). Results: The average resection weight was 551.7 g (range, 176-1827 g), with 4.6% of resections greater than 1000 g. A majority of patients (55.2%) concomitantly underwent liposuction of the breast. The total complication rate was 22.7%, with superficial dehiscence (8.8%) and hypertrophic scarring (8.8%) comprising the majority. Nipple sensory changes occurred in 1.6% of breasts, with no episodes of nipple necrosis. The revision rate was 2.2%. Patients with complications had significantly higher resection volumes and nipple-to-fold distances (P = .014 and .010, respectively). Conclusions: The vertical-style superomedial pedicle reduction mammaplasty is safe and effective for a wide range of symptomatic macromastia. The nipple-areola complex can be safely transposed, even in patients with larger degrees of macromastia, with no episodes of nipple necrosis. The adjunctive use of liposuction should be considered safe. Last, revision rates were low, correlating with a high level of patient satisfaction.     

Reduction mammaplasty using superior pedicle in macromastia

SUBJECT: The authors present technical details, complications, morphologic and aesthetic results of 26 breast reduction mammaplasty for macromastia (breast reduction more than 1000 g) showing advantages and reliability of technique. MATERIALS AND METHODS: From January 2000 to December 2001, 223 patients underwent bilateral reduction mammaplasty with superior-based pedicled dermo-glandular flap. In 26 of them the weight of removed mammary tissue was over 1000 g in each breast. These 26 cases were evaluated, and the criteria adopted to analyse the results was morphologic and aesthetic evaluation of patient herself (very good, good, acceptable, unacceptable). RESULTS: Mean follow-up for all patients was 15 months. Twenty-six patients (mean age 33.2 years) underwent an average weight of 1131 g (930/2200 g) removed per breast. The following complications were observed: 1 Nipple Areolar Complex ischemia without necrosis; three infections (abscess); four delayed wound closure. The patient subjective evaluation of result was: "very good" in 19 cases (73%); "good" in 5 cases (19.2%) and "acceptable" in the others two cases (7.8%). No case was evaluated "unacceptable". CONCLUSION: Superior dermoglandular pedicle mammaplasty represent a very good and reliable solution for the treatment of macromastia, giving satisfactory cosmetics results with good nipple viability without necrosis. This technique is actually our first choice in the management of macromastia.     

The effect of obesity on early outcomes in adolescents undergoing reduction mammaplasty

It is not known whether obesity portends poorer outcomes following reduction mammaplasty in adolescent macromastia patients. We review symptoms in obese and nonobese adolescent macromastia patients and describe early outcomes following reduction mammaplasty. Demographics, operative details, and postoperative follow-up data were collected on 67 patients seen at our institution between 1997 and 2008. Variables were compared using 2-sample t tests or Pearson χ/Fisher exact tests. Mean age at surgery was 17.1 ± 1.6 years. Mean body mass index was 27.9 ± 4.5 kg/m, and 32.8% were obese. Thirty-four patients (50.7%) experienced minor complications; 1 patient experienced a major complication. Of patients with complications, obese patients reported a greater number than nonobese patients (P = 0.013). There were no differences in the type of complication or self-reported satisfaction between obese and nonobese patients 34.4 ± 25.7 weeks after surgery. Our findings suggest that reduction mammaplasty is well-tolerated in obese and nonobese adolescents with macromastia and that obesity is not an absolute contraindication to reduction mammaplasty in adolescents.     

Reduction Mammaplasty in a Developing Country: A Guideline for Plastic Surgeons for Patient Selection

Background  

In Ghana and most developing countries there has been no standardized study of reduction mammaplasty (RM) in patients with symptomatic macromastia (SM), despite its debilitating effects. This study aimed to analyze the physical and psychological effects associated with female patients who underwent reduction mammaplasty and to develop a guideline for plastic surgeons in developing countries to know the most important signs and symptoms to consider in SM patients.     

直线法乳房成形术的临床应用

目的介绍直线法乳房成形术(Lejour法)及其改进方法。方法按Lejour法设计手术切口,剥离乳腺组织,仅保留上部蒂营养乳头、乳晕,去除部分肥大下部及基底乳腺组织,将剩余腺体组织的乳腺基底层固定于第2、3肋水平。重新塑形乳腺组织,皮肤无张力缝合。对于部分乳房肥大明显患者可以首先抽吸脂肪,主要减少乳房腺体内、外侧及侧胸部皮下脂肪。结果采用此法矫治巨乳症、单纯乳房下垂共48例,其中辅助脂肪抽吸13例,术后乳房外形美观,术后3个月随访,3例有修整乳晕瘢痕或乳房下皱襞瘢痕。结论本术式简便易行,且远期效果好,乳房外形挺拔,可作为乳房缩小悬吊术的可行术式之一。